Cell therapy for Parkinson's disease: Problems and prospects

Novartis Foundation Symposium

Volumn 265, Issue , 2005, Pages 174-186

  Björklund, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

CELL DIFFERENTIATION; CYTOLOGY; HUMAN; METABOLISM; NERVE CELL; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION;

CELL DIFFERENTIATION; DOPAMINE; HUMANS; NEURONS; PARKINSON DISEASE; STEM CELL TRANSPLANTATION;

EID: 23844490926     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (43)

1. Agid Y, Javoy-Agid F, Ruberg M 1987 Biochemistry of neurotransmitter in PD. In: Marsden CD, Fahn S (eds) Movement disorders 2. Butterworth, London, p 166-230
2. Baker-Cairns BJ, Sloan DJ, Broadwell RD, Puklavec M, Charlton HM 1996 Contributions of donor and host blood vessels in CNS allografts. Exp Neurol 142:36-46
3. Björklund A 1992 Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr Opin Neurobiol 2:683-689
4. Björklund LM, Sanchez-Pernaute R, Chung S et al 2002 Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99:2344-2349
5. Braak H, Braak E 2000 Pathoanatomy of Parkinson's disease. J Neurol 247(suppl 2):II3-10
6. Brundin P, Hagell P 2002 The neurobiology of cell transplantation in Parkinson's disease. Clin Neurosci Res 1:507-520
7. Brundin P, Barbin G, Strecker RE, Isacson O, Prochiantz A, Björklund A 1988 Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Brain Res 467:233-243
8. Carvey PM, Lin DH, Faselis CJ, Notermann JK, Ling ZD 1996 Loss of striatal DA innervation increases striatal trophic activity directed at DA neurons in culture. Exp Neurol 140:184-197
9. Chung S, Sonntag KC, Andersson T et al 2002 Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 16:1829-1838
10. Duan W-M, Widner H, Björklund A, Brundin P 1993 Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected? Neuroscience 57:261-274
11. Dunnett SB, Björklund A, Lindvall O 2001 Cell therapy in Parkinson's disease - stop or go? Nat Rev Neurosci 2:365-369
12. Freed CR, Greene PE, Breeze RE et al 2001 Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New Engl J Med 344:710-719
13. Hagell P, Brundin P 2001 Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 60:741-752
14. Haque NS, LeBlanc CJ, Isacson O 1997 Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Cell Transplant 6:239-248
15. Hudson JL, Hoffman A, Stromberg I, Hoffer BJ, Moorhead JW 1994 Allogeneic grafts of fetal dopamine neurons: behavioral indices of immunological interactions. Neurosci Lett 171:32-36
16. Isacson O, Bjorklund LM, Schumacher MD 2003 Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann Neurol 53(suppl 3):S135-S148
17. Kim JH, Auerbach JM, Rodriguez-Gomez JA et al 2002 Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56
18. Kirik D, Winkler C, Björklund A 2001 Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci 21:2889-2896
19. Kordower JH, Freeman TB, Snow BJ et al 1995 Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124
20. Kordower JH, Rosenstein JM, Collier TJ et al 1996 Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 370:203-230
21. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD 2000 Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18:675-679
22. Lindvall O 2003 Stem cells for cell therapy in Parkinson's disease. Pharmacol Res 47:279-287
23. Lindvall O, Hagell P 2000 Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res 127:299-320
24. Ling ZD, Potter ED, Lipton JW, Carvey PM 1998 Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 149:411-423
25. Ling ZD, Collier TJ, Sortwell CE et al 2000 Striatal trophic activity is reduced in the aged rat brain. Brain Res 856:301-309
26. Nikkhah G, Cunningham MG, Jödicke A, Knappe U, Björklund A 1994 Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 633:133-143
27. Olanow CW, Goetz CG, Kordower JHet al 2003 A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54:403-414
28. Perl DP, Olanow CW, Calne D 1998 Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 44 (suppl 1):S19-S31
29. Piccini P, Lindvall O, Bjorklund A et al 2000 Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 48:689-695
30. Potter ED, Ling ZD, Carvey PM 1999 Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res 296:235-246
31. Schultzberg M, Dunnett SB, Björklund A et al 1984 Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation. Neuroscience 12:17-32
32. Shinoda M, Hudson JL, Stromberg I, Hoffer BJ, Moorhead JW, Olson L 1995 Allogeneic grafts of fetal dopamine neurons: immunological reactions following active and adoptive immunizations. Brain Res 680:180-195
33. Shinoda M, Hudson JL, Stromberg I, Hoffer BJ, Moorhead JW, Olson L 1996 Microglial cell responses to fetal ventral mesencephalic tissue grafting and to active and adoptive immunizations. Exp Neurol 141:173-180
34. Sloan DJ, Baker BJ, Puklavec M, Charlton HM 1990 The effect of site of transplantation and histocompatibility differences on the survival of neural tissue transplanted to the CNS of defined inbred rat strains. Prog Brain Res 82:141-152
35. Sortwell CE, Camargo MD, Pitzer MR, Gyawali S, Collier TJ 2001 Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp Neurol 169:23-29
36. Studer L, Tabar V, McKay RD 1998 Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1:290-295
37. Studer L, Csete M, Lee SH et al 2000 Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20:7377-7383
38. Svendsen CN, Caldwell MA 2000 Stem cells in the developing central nervous system: implications for cell therapy through transplantation. Prog Brain Res 127:13-34
39. Wenning GK, Odin P, Morrish P et al 1997 Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 42:95-107
40. Winkler C, Bentlage C, Nikkhah G, Samii M, Björklund A 1999 Intranigral transplants of Gabarich Striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 155:165-186
41. Winkler C, Kirik D, Björklund A, Dunnett SB 2000 Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Prog Brain Res 127:233-265
42. Yurek DM, Fletcher-Turner A 2001 Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion. Brain Res 891:228-235
43. Yurek DM, Fletcher-Turner A 2002 Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons. Brain Res 931:126-134